Grunenthal

is a Germany-based pharmaceutical company that develops and markets pain management products for patients worldwide...
Read more
Grunenthal Chairman & CEO: Gabriel Baertschi

Chairman & CEO

Gabriel Baertschi

CEO Approval Rating

80/100

Est. Annual Revenue
$1.0-5.0B
Agree?
Est. Employees
1.0-5.0K
Agree?
Funding
$852.9M
Acquisitions
8

Grunenthal Competitors

1Endo
2UCB
3Salix Pharmaceuticals
4Takeda Pharmaceutical
5AbbVie
6Zogenix
7Viatris
8Jazz Pharmaceuticals
9Acorda
10Sentynl Therapeutics

Trending Companies